Evidence map›Paper›PMID 42254819›Full record

ArticleAdvances in radiation oncology2026

Hypothesis Generation via Interpretable Machine Learning: A Case Study on Risk Factors for Postradiation Therapy Lung Cancer Recurrence.

Zheng Zhang, Sang Ho Lee, Rich Caruana, Harsha Nori, Yong Fan, Xingmei Wang, Nikhil Yegya-Raman, Charles B Simone, Gary D Kao, Steven J Feigenberg and 1 more

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zheng ZhangDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Sang Ho LeeDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Rich CaruanaMicrosoft Research, Redmond, Washington.
Harsha NoriMicrosoft Research, Redmond, Washington.
Yong FanDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.
Xingmei WangDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
Nikhil Yegya-RamanDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Charles B SimoneDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Gary D KaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Steven J FeigenbergDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Ying XiaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Purpose: Interpretability is highly desirable for oncologic outcome prediction, as it increases the level of transparency and trustworthiness of the model. This model characteristic is particularly relevant in the setting of modest sample size. Existing work has focused on Shapley Additive Explanations to provide post-hoc explanations on black-box models. These models are not intrinsically interpretable. In this study, we investigated the applicability of an intrinsically interpretable glass-box model, Explainable Boosting Machine (EBM), for hypothesis generation from an early-stage lung cancer data set. Methods and Materials: We applied EBM to a stripped data set on postradiation therapy lung cancer recurrence, aiming to extract as much information as possible by using pristine EBM configurations. We compared the key features ranked by EBM with those identified through univariate statistical analysis. Additionally, we benchmarked its performance against logistic regression and random forest models, while also evaluating the hypotheses generated by EBM. This study was approved by an institutional review board at the University of Pennsylvania. Results: EBM identified primary tumor size and body mass index as the most prognostic features, aligning with the results of the univariate analysis. Its interpretability provides safeguards against misinterpretation; the model revealed potential age-related bias in this single-arm data set and possible confounding interactions between race and body mass index. EBM yielded competitive performances and more interpretable insights compared with logistic regression and random forest but was not immune from generalizability challenges arising from limited data. Conclusions: The modest performance prevents EBM from being used as a clinical decision support tool, when applied to limited data. However, its interpretable, glass-box nature makes it useful for hypothesis generation.

Identifiers

PMID42254819
PMCPMC13242006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.